APOTHEEK COPPIN
ActiveSummary
APOTHEEK COPPIN has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €258,769 and a net result of €190,921. Equity has been stable since 2018 (±1.3% per year). Its solvency ranks better than 29% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
Source: KBO- Status
- Active since 02-01-1986 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment units
- 2.196.543.818 8400 Oostende, since 01-02-1986
- 2.216.430.501 8400 Oostende, since 28-01-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 05-06-2025
Board and ownership
- PERVANTIDirector · since 01-01-2013 · permanent representative PERSYN Ilse Maria Johanna
- PERVANTI99.87%2025 annual accounts of PERVANTI
- Ilse Persynannual accounts 2018
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Gross margin
- €582,813
- ▲ 8.8%
- Turnover
- ≈ €2.1m
- estimated
- Profit
- €190,921
- ▲ 15.0%
- Equity
- €258,769
- ▲ 0.5%
- Total assets
- €1.4m
- ▲ 2.0%
- Employees on 31-12-2025
- 5
- ▼ 16.7%
Score breakdownraises riskSector: Retail trade (NACE 47)Equity €258,769 (18.3% of total assets)lowers riskFounded in 1986Liquidity: current ratio 0.98, cash €281,913Show the evidence
Checked score
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 34% of them on solvency, 35% on liquidity, 80% on profitability and 41% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 19 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Company renamed from APOTEEK COPPIN to APOTHEEK COPPINChange of role: PERVANTI, from manager to director · Resignation: COPERMA (manager) · Permanent representatives: COPPIN Martine and PERSYN Ilse Maria Johanna
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as APOTHEEK COPPIN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.6m, founded between 1986 and 1991.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK COPPIN Oostende | €1.4m | €0.6m |
| Romarix Liedekerke | €1.4m | €0.6m |
| APOTHEEK VERSTRAETE Kortrijk | €1.5m | €0.6m |
| APOTHEEK COENE Zonnebeke | €1.2m | €0.6m |
| Apotheek Vichte Anzegem | €1.1m | €0.6m |
| Pharmacie de Lillois Braine-l'Alleud | €1.6m | €0.6m |
| Pharmacie de Bavière Liège | €1.4m | €0.5m |
Key facts about APOTHEEK COPPIN
- What is the company number of APOTHEEK COPPIN?
- The company number of APOTHEEK COPPIN is 0428.263.809. The VAT number is the same number with BE in front: BE 0428.263.809.
- Where is APOTHEEK COPPIN based?
- The registered office is at Louisastraat 2, 8400 Oostende.Company details
- What does APOTHEEK COPPIN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK COPPIN?
- The legal form of APOTHEEK COPPIN is Private limited company (BV).
- When was APOTHEEK COPPIN founded?
- APOTHEEK COPPIN was founded on 02-01-1986.
- Is APOTHEEK COPPIN still active?
- Yes, APOTHEEK COPPIN is an active enterprise in the KBO register.
- How many employees does APOTHEEK COPPIN have?
- APOTHEEK COPPIN had an average of 3.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK COPPIN fall under?
- In its 2025 annual accounts, APOTHEEK COPPIN states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTHEEK COPPIN?
- The turnover in financial year 2025 is ≈ €2.1m. This figure is estimated from the gross margin of €582,813 and 47 comparable companies (NACE 477). It probably lies between €1.6m and €3.5m.
- Is APOTHEEK COPPIN profitable?
- In financial year 2025, APOTHEEK COPPIN made a profit of €190,921.
- Where can I find the annual accounts of APOTHEEK COPPIN?
- APOTHEEK COPPIN filed 40 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK COPPIN due?
- APOTHEEK COPPIN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.